Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Xtant Medical Holdings (XTNT) Consolidated Net Income (2016 - 2025)

Xtant Medical Holdings has reported Consolidated Net Income over the past 16 years, most recently at $57000.0 for Q4 2025.

  • Quarterly Consolidated Net Income rose 101.8% to $57000.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $5.0 million through Dec 2025, up 130.23% year-over-year, with the annual reading at $5.0 million for FY2025, 130.23% up from the prior year.
  • Consolidated Net Income was $57000.0 for Q4 2025 at Xtant Medical Holdings, down from $1.3 million in the prior quarter.
  • Over five years, Consolidated Net Income peaked at $9.2 million in Q3 2023 and troughed at -$6.2 million in Q4 2023.
  • The 5-year median for Consolidated Net Income is -$2.1 million (2023), against an average of -$1.3 million.
  • Year-over-year, Consolidated Net Income crashed 7531.03% in 2022 and then soared 492.31% in 2023.
  • A 5-year view of Consolidated Net Income shows it stood at -$2.4 million in 2021, then increased by 7.07% to -$2.2 million in 2022, then crashed by 180.85% to -$6.2 million in 2023, then surged by 48.98% to -$3.2 million in 2024, then skyrocketed by 101.8% to $57000.0 in 2025.
  • Per Business Quant, the three most recent readings for XTNT's Consolidated Net Income are $57000.0 (Q4 2025), $1.3 million (Q3 2025), and $3.6 million (Q2 2025).